Quell Therapeutics Limited
Clinical trials sponsored by Quell Therapeutics Limited, explained in plain language.
-
Engineered immune cells take on tough autoimmune diseases
Disease control Recruiting nowThis early-stage trial tests an experimental treatment called QEL-005 in 16 adults with two serious autoimmune conditions: diffuse cutaneous systemic sclerosis and difficult-to-treat rheumatoid arthritis. QEL-005 is made from a patient's own white blood cells, which are genetical…
Phase: PHASE1, PHASE2 • Sponsor: Quell Therapeutics Limited • Aim: Disease control
Last updated May 17, 2026 03:58 UTC
-
Blood cell research could pave way for new immune treatments
Knowledge-focused Recruiting nowThis study looks at white blood cells from healthy volunteers and people with autoimmune diseases, inflammation, or liver transplant rejection. The goal is to understand these cells better so scientists can create new engineered regulatory T cell (Treg) therapies. The study invol…
Sponsor: Quell Therapeutics Limited • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC